Cargando…

Glioblastomas

Detalles Bibliográficos
Autores principales:	Finocchiaro, Gaetano, Berzero, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744915/ https://www.ncbi.nlm.nih.gov/pubmed/35008268 http://dx.doi.org/10.3390/cancers14010104

Ejemplares similares

The coming of age of liquid biopsy in neuro-oncology
por: Berzero, Giulia, et al.
Publicado: (2023)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells
por: Behnan, Jinan, et al.
Publicado: (2016)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma
por: Tunici, Patrizia, et al.
Publicado: (2004)

Hypoxia and glioblastoma therapy
por: Yang, Chunzhang, et al.
Publicado: (2015)

Glioblastoma in older adults
por: Holdhoff, Matthias, et al.
Publicado: (2018)

T-cell exhaustion in glioblastoma
por: Woroniecka, Karolina, et al.
Publicado: (2018)

Bevacizumab in recurrent glioblastoma
por: Martinez, Nina L., et al.
Publicado: (2019)

What is a glioblastoma?
por: Lassman, Andrew B, et al.
Publicado: (2023)

Current therapeutic approaches to diffuse grade II and III gliomas
por: Picca, Alberto, et al.
Publicado: (2018)

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

The need for geriatric scales in glioblastoma
por: Domenech, Marta, et al.
Publicado: (2021)

Molecular and Cellular Mechanisms of Glioblastoma
por: Castresana, Javier S., et al.
Publicado: (2021)

Basic and Translational Advances in Glioblastoma
por: Piccirillo, Sara G. M., et al.
Publicado: (2018)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

MIF: functions in brain and glioblastoma
por: Ohta, Shigeki, et al.
Publicado: (2017)

Novel Treatment Strategies for Glioblastoma
por: Stylli, Stanley S.
Publicado: (2020)

Current Therapeutic Strategies for Glioblastoma
por: Rossignol, Julien, et al.
Publicado: (2019)

Targeted Molecular Therapy in Glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2020)

Glioblastoma: an organ-confined disease?
por: Cabezas-Camarero, Santiago, et al.
Publicado: (2022)

Recurrent Glioblastoma: What Is the Route?
por: Bosio, Alberto, et al.
Publicado: (2023)

Macrophages in the Glioblastoma Tumor Microenvironment
por: Coniglio, Salvatore J.
Publicado: (2023)

SERPINA3 in glioblastoma and Alzheimer’s disease
por: Norton, Emily S., et al.
Publicado: (2021)

Mouse models of radiation-induced glioblastoma
por: Mukherjee, Bipasha, et al.
Publicado: (2015)

On the subventricular zone origin of human glioblastoma
por: Mistry, Akshitkumar M.
Publicado: (2019)

Glioblastoma: State of the Art and Future Perspectives
por: Tabatabai, Ghazaleh, et al.
Publicado: (2019)

Why is immunotherapy for glioblastoma “Lag”-ging
por: Mathios, Dimitrios, et al.
Publicado: (2019)

Molecular Biology in Glioblastoma Multiforme Treatment
por: Abbruzzese, Claudia, et al.
Publicado: (2022)

Glioblastoma Biology, Genetics and Possible Therapies
por: Castresana, Javier S., et al.
Publicado: (2023)

Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
por: Aquino, Domenico, et al.
Publicado: (2014)

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
por: Frattini, Véronique, et al.
Publicado: (2012)

A role for the transcription factor HEY1 in glioblastoma
por: Hulleman, Esther, et al.
Publicado: (2009)

Novel Treatment Strategies for Glioblastoma—A Summary
por: Stylli, Stanley S.
Publicado: (2021)

Prognostic and predictive markers in glioblastoma and ALK overexpression
por: Kim, Jang-Hee
Publicado: (2021)

Current and Future Novel Treatments for Glioblastoma Multiforme
por: Tyler, Betty, et al.
Publicado: (2014)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
por: Cuccarini, Valeria, et al.
Publicado: (2019)

PGE(2) Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma
por: Nava, Sara, et al.
Publicado: (2020)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_raiqd038irfebr4techu4nt1j9